Evidence map›Paper›PMID 36925680›Full record

ReviewBioengineering & translational medicine2023

Modulating neuroinflammation through molecular, cellular and biomaterial-based approaches to treat spinal cord injury.

Cheryl Yi-Pin Lee, Wai Hon Chooi, Shi-Yan Ng, Sing Yian Chew

Open access · goldFull text readReview
In one paragraph

Review in Bioengineering & translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Identification of immune-related hub genes in spinal cord injury.European journal of medical research · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Cheryl Yi-Pin LeeInstitute of Molecular and Cell Biology ASTAR Research Entities Singapore Singapore.ORCID https://orcid.org/0000-0002-5265-0377
Wai Hon ChooiInstitute of Molecular and Cell Biology ASTAR Research Entities Singapore Singapore.ORCID https://orcid.org/0000-0003-0268-0938
Shi-Yan NgInstitute of Molecular and Cell Biology ASTAR Research Entities Singapore Singapore.ORCID https://orcid.org/0000-0003-3418-2757
Sing Yian ChewSchool of Chemical and Biomedical Engineering Nanyang Technological University Singapore Singapore.
Agency for Science, Technology and Research · SGNanyang Technological University · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neuroinflammatory response that is elicited after spinal cord injury contributes to both tissue damage and reparative processes. The complex and dynamic cellular and molecular changes within the spinal cord microenvironment result in a functional imbalance of immune cells and their modulatory factors. To facilitate wound healing and repair, it is necessary to manipulate the immunological pathways during neuroinflammation to achieve successful therapeutic interventions. In this review, recent advancements and fresh perspectives on the consequences of neuroinflammation after SCI and modulation of the inflammatory responses through the use of molecular-, cellular-, and biomaterial-based therapies to promote tissue regeneration and functional recovery will be discussed.

Indexed as

central nervous systeminflammatory responsenerve regenerationneural tissue engineeringtissue engineering scaffolds

Identifiers

PMID36925680
PMCPMC10013833
OpenAlexW4293742258

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read23
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.